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The main objective of this study was to assess the effects of 4 g kg−1 dietary mannan 
oligosaccharides (MOS) inclusion in soybean oil (SBO)- and fish oil (FO)-based diets on 
the gut health and skin mucosa mucus production of European sea bass juveniles after 
8 weeks of feeding. Dietary MOS, regardless of the oil source, promoted growth. The 
intestinal somatic index was not affected, however dietary SBO reduced the intestinal fold 
length, while dietary MOS increased it. The dietary oil source fed produced changes on 
the posterior intestine fatty acid profiles irrespective of MOS dietary supplementation. SBO 
down-regulated the gene expression of TCRβ, COX2, IL-1β, TNFα, IL-8, IL-6, IL-10, TGFβ, 
and Ig and up-regulated MHCII. MOS supplementation up-regulated the expression of 
MHCI, CD4, COX2, TNFα, and Ig when included in FO-based diets. However, there was 
a minor up-regulating effect on these genes when MOS was supplemented in the SBO-
based diet. Both dietary oil sources and MOS affected mean mucous cell areas within the 
posterior gut, however the addition of MOS to a SBO diet increased the mucous cell size 
over the values shown in FO fed fish. Dietary SBO also trends to reduce mucous cell den-
sity in the anterior gut relative to FO, suggesting a lower overall mucosal secretion. There 
are no effects of dietary oil or MOS in the skin mucosal patterns. Complete replacement 
of FO by SBO, modified the gut fatty acid profile, altered posterior gut-associated immune 
system (GALT)-related gene expression and gut mucous cells patterns, induced shorter 
intestinal folds and tended to reduce European sea bass growth. However, when combined 
with MOS, the harmful effects of SBO appear to be partially balanced by moderating the 
down-regulation of certain GALT-related genes involved in the functioning of gut mucous 
barrier and increasing posterior gut mucous cell diffusion rates, thus helping to preserve 
immune homeostasis. This denotes the importance of a balanced dietary n–3/n–6 ratio 
for an appropriate GALT-immune response against MOS in European sea bass juveniles.
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introduction
The continuous expansion of the aquaculture sector requires 
securing access to sustainable feed ingredients for intensively 
cultured fish feed production (1). Over the last 20  years, the 
aquaculture sector has made a considerable effort to study 
vegetable oils (VOs) as potential substitutes for fish oil (FO) 
in aquaculture feeds. However, VOs deficiency in long-chain 
polyunsaturated fatty acids (LC-PUFAs) and their high 18:C 
and n–6 fatty acids contents limit their use in aqua feeds, 
particularly for marine fish species. Marine fish generally have 
a low Δ6 and Δ5 fatty acyl desaturase activity (2–4) and a low 
expression of the corresponding genes, despite a certain range 
of expression modulation through the diet (5), and therefore, 
their ability to synthesize LC-PUFA from n–6 and n–3 pre-
cursors present in VO is very limited. Thus, VO inclusion in 
marine fish diets reduces the presence of essential fatty acids 
and alters the n–3/n–6 fatty acids balance and may negatively 
affect not only fish performance, but also fish health and disease 
resistance (6).
The negative effect of unbalanced dietary n–3/n–6 fatty acids 
on marine fish immune competence may depend on the VO 
fatty acid profile, the VO dietary inclusion levels and the specific 
ability of the fish species to synthesize LC-PUFA (6). Dietary 
inclusion of VOs changes the fatty acid composition of cell mem-
branes (6–10), affecting cell function through the modification 
of the membrane bound enzymes and receptors activities (10, 
11). Thus, dietary VOs have been associated with fluctuations 
on the immune cellular population proportions (10), altered 
intracellular and extracellular leukocytes killing capacity (9, 
10, 12–19), variations in humoral response (9, 12, 15, 17, 18), 
variations in several physiological processes such as eicosanoids 
production (4, 9, 20–27), and modulation of signaling molecules 
and regulators of gene expression (6, 18, 26, 28). Specifically, 
dietary VO causes several changes in fish that could favor 
intestinal dysfunction, such as variations in tissue composition 
and morphology (19, 29–34), intestinal functionality (6, 35–38), 
variations in microbiota profiles (39, 40), or alterations in the 
gut-associated immune system (GALT) function (6). In addi-
tion, dietary alterations could stimulate the rate of production 
of mucous (41–43) and its biochemical composition (44), thus 
regulating the intestinal dynamic barrier formed by epithelium 
cells (45).
One of the possible strategies to counteract the side effects of 
high dietary VO on fish health, other than balancing the n–3/n–6 
ratio with VO blends, could be to incorporate natural feed addi-
tives, such as mannan oligosaccharides (MOS), that would help 
to maintain tissue structure and promote the innate immune 
system. Dietary MOS has been demonstrated to promote fish 
performance and disease resistance by stimulating the systemic 
and GALT systems and by reinforcing the gut epithelial barrier 
structure and functionality in FO-based diets (44).
Thus, the main objective of this study is to assess the effects 
of dietary MOS supplementation in soybean oil (SBO)- and 
FO-based diets on the gut health of European sea bass 
(Dicentrarchus labrax) juveniles in relation to gut morphology 
and functionality.
Materials and Methods
Diets
Diets were designed to contain FO or SBO as the single lipid 
source in combination with 4 g  ⋅ kg−1 MOS (Biomos®; Alltech, 
Inc., USA) replacing standard carbohydrates (corn meal) 
(FOMOS and SBOMOS). Extruded diets (2–3 mm slow sinking 
pellets; 6–8% moisture) were isolipidic and isoproteic and manu-
factured by Sparos, Lda (CRIA-Universidade do Algarve, Faro, 
Portugal). Dietary formulation, proximate composition, and fatty 
acid profiles are indicated in Tables 1 and 2.
experimental conditions
Prior to the feeding trial, European sea bass juveniles (960 
fish) were maintained in stocking tanks and fed a commercial 
extruded diet for three weeks. Fish were then randomly distrib-
uted in 12 indoor cylindroconical 1000 L fiberglass tanks at an 
initial stocking density of 1.7 kg ⋅ m−3 (80 fish/tank). Fish average 
initial weight and length were 20.63 ± 0.12 g and 11.73 ± 0.07 cm, 
respectively (mean ± SD). Tanks were supplied with filtered sea 
water at a temperature of 19.0–20.3°C in a flow-through system 
and natural photoperiod (12L:12D). Dissolved oxygen oscillated 
between 7.3 and 8.1 ppm. Fish were manually fed until apparent 
satiation with one of the four experimental diets for 60 days (three 
times a day, 6 days a week). Each dietary treatment was assayed 
in triplicate.
Sampling was performed after 60  days of feeding. All fish 
were sampled for final weight and length after 24  h of starva-
tion. Ten fish per tank were sampled individually for skin and 
gut histological studies. Additionally, posterior gut of six fish per 
tank was taken and quickly kept in RNA later and frozen at −80°C 
TaBle 1 | Main ingredients and composition of the experimental diets.
ingredient Diet (g ⋅ kg−1 dry weight)
FO FOMOs sBO sBOMOs
Fish meala 515.0 515.0 515.0 515.0
Soybean mealb 97.8 97.8 97.8 97.8
Wheat 85.3 85.3 85.3 85.3
Wheat gluten 85.3 85.3 85.3 85.3
Corn mealc 65.3 61.3 65.3 61.3
Fish oild 147.2 147.2 0 0
Soybean oil 0 0 147.2 147.2
Mineral and 
vitamin mixe
4 4 4 4
Antioxidant 
(BHT)
0.1 0.1 0.1 0.1
MOSf 0 4 0 4
composition (%, dry weight)
Crude lipids 21.12 21.55 21.23 21.23
Crude protein 48.18 48.77 47.71 47.43
Moisture 4.29 4.73 3.91 3.90
Ash 10.55 10.42 11.46 11.41
aPeruvian fish meal (67% crude protein; 9% crude fat; EXALMAR, Peru).
bSoybean meal (Solvent extracted dehulled soybean meal; 47% crude protein; 2.6% 
crude fat; SORGAL SA, Portugal).
cCorn meal (8–12% crude protein).
dPeruvian fish oil.
eMineral and vitamin premix provided by BioMar SAS.
fBiomos®, Alltech, Inc., USA.
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until gene expression analysis. Five fish per tank were sampled for 
intestinal somatic index (ISI), after 24 h of starvation, and pooled 
for posterior gut proximate composition and fatty acid analyses. 
The animal experiments described comply with the guidelines 
of the European Union Council (2010/63/EU) for the use of 
experimental animals and have been approved by the Bioethical 
Committee of the University of Las Palmas de Gran Canaria.
Biochemical analyses
Feed and tissue biochemical composition analyses were carried 
out using standard procedures (46). Crude protein content 
(Nx6.25) was determined by the Kjeldahl method and crude lipid 
was analyzed as described in Ref. (47). Moisture was determined 
by thermal dehydration to constant weight at 110°C. Ash content 
was determined by combustion at 600°C for 12  h. Fatty acid 
methyl esters profiles were prepared by transmethylation (48) and 
separated by gas chromatography (GC-14A, Shimadzu, Japan) 
following the conditions described in reference (49). Fatty acid 
methyl esters quantification was performed using a flame ioniza-
tor detector and identification by comparison with external and 
well-characterized FOs standards (EPA 28, Nippai, Ltd., Tokyo, 
Japan). All analyses were conducted in triplicate.
histological studies
Gut Morphometric Analyses
Fish intestines were dissected out and six to eight transversal sec-
tions of the posterior intestine (from the first diffused sphincter 
to rectum sphincter; N = 15 per group) were fixed in 4% neutral-
buffered formalin and embedded in paraffin perpendicularly to 
the bottom of the mold. For each specimen, six serial sections 
(5 μm thick) were stained with H&E and/or specific Alcian Blue/
PAS staining (pH = 2.5) (50). Micrographs were taken at a final 
magnification of 200× and 400× using a Nikon Microphot-
FXA microscope and an Olympus DP50 camera (n = 5 × 5 per 
individual fish; 125 images per feeding group). Mucosal fold 
height and width were determined using an analySIS® (Image 
Pro Plus®, Media Cybernetics, Silver Spring, MD, USA) software 
package (51).
Mucosal Mapping
Sections of skin (from the dorsolateral area just below the dorsal 
fin), anterior, and posterior gut (five fish/tank; N = 15 groups) 
were removed at necropsy and fixed in buffered 4% formalin. 
The tissues were dehydrated in a series of ethanol dilutions and 
embedded progressively in Technovit (Electron Microscopy 
Sciences, PA, USA). Histological sections of 3 μm thickness 
were stained with PAS-Alcian Blue for unequivocal marking 
of mucous cells. The stereological analysis was performed 
from live images of sections with Visiopharm v.3.0 software 
(Visiopharm, Hoersholm, Denmark). Mucosal Mapping [see 
Ref. (52) for details] was applied to the intestinal and skin 
mucosal tissues to evaluate responses in the innate immune 
system. Five unbiased measures were obtained: epithelial tissue 
area (μm2), number of mucous cells, mucus cell area (μm2) with 
a correction factor for plane of sectioning (53), mucous cell 
density in the epithelium (%), and ratio of epithelium to mucus 
cell (E:M).
rna extraction and real-Time  
Quantitative Pcr analysis
Total RNA of the fish posterior intestine (N = 2 pools of three 
fish/tank; N = 6/diet) was extracted using TRI reagent (Sigma-
Aldrich, Saint Louis, MO, USA) and quantified by spectro-
photometry (Nanodrop 1000, Themo Fisher Scientific Inc., 
USA). The integrity of RNA was verified by Gel RedTM staining 
(Biotium Inc., Hayward, CA, USA) on a 1.4% agarose gel. The 
reverse transcription (RT) reactions were performed using the 
iScriptTMcDNA Synthesis Kit (Bio-Rad Hercules, California) in 
20-μL reaction volume containing 1 μg of total RNA.
Fifteen genes involved in the immune system response (IL-
1β, IL-10, TNFα, IL-8, IL-6, CD4, CD8α, MHCI, MHCII, TCRβ, 
TGFβ, COX2, Ig, Caspase 3, and Caspase 9) were analyzed by real-
time PCR, using β-actin as housekeeping gene. The PCRs were 
carried out in aI-cycler with optical module (Bio-Rad Hercules, 
CA, USA) in a final volume of 20 μL containing 10 μL of Brillant 
SYBR Green QPCR Master Mix (Bio-Rad Hercules, CA, USA), 
0.6 μL of each primer (10 mM), and 2 μL of cDNA (1:10 dilution). 
The PCR conditions for genes CD4, CD8α, MHCI, MHCII, TCRβ, 
TGFβ, COX2, IL-10, and Ig were as follows: 95°C for 10 min, fol-
lowed by 35 cycles of 95°C for 45 s, 52°C for 45 s and 72°C for 
45 s, as described before (54). Reaction mixtures for genes IL-8, 
IL-6, Caspase 3, and 9 were incubated for 10 min at 95°C, followed 
by 35 cycles of 45 s at 95°C, 45 s at 60°C, and 72°C for 45 s. The 
cycling conditions for IL-1β and TNFα were 95°C for 10  min, 
followed by 40 cycles of 95°C for 15 s, 58°C for 30 s, and 72°C 
for 30 s. Each run ended with a melting curve analysis resulting 
in a melting peak profile specific for the amplified target DNA. 
Reactions were performed in duplicate for each template cDNA. 
Blank control reactions replaced cDNA with water. Relative gene 
expression was estimated by the Δ–Δ method (55). The specific 
primers used are indicated in Table 3.
statistical analyses
All data were tested for normality and homogeneity of variance. 
Means and SDs were calculated for each parameter measured. 
When required, data arcsine square root transformation was 
performed, particularly when data were expressed as % (56). 
Statistical analyses followed methods outlined in ref. (57). The 
effects of oil source (SBO and FO) and MOS supplementation 
(0 or 4 g  ⋅ kg−1) were analyzed by two-way ANOVA, where oil 
TaBle 2 | Main fatty acids composition (% of total identified fatty acids) 
of experimental diets.
FO FOMOs sBO sBOMOs
Saturated 11.72 ± 0.06 11.75 ± 0.02 5.72 ± 0.02 5.75 ± 0.02
Monoens 25.81 ± 0.37 25.89 ± 0.04 27.08 ± 2.16 24.57 ± 1.18
n–3 34.00 ± 0.10 34.35 ± 0.01 9.72 ± 1.10 10.87 ± 1.32
n–6 7.06 ± 0.21 6.72 ± 0.04 42.86 ± 1.14 44.25 ± 0.25
n–9 9.97 ± 0.04 9.78 ± 0.02 22.20 ± 1.63 19.91 ± 0.14
n–3 LC-PUFA 28.63 ± 0.08 28.96 ± 0.05 4.35 ± 0.93 5.28 ± 1.38
n–3/n–6 4.82 ± 0.13 5.11 ± 0.03 0.24 ± 0.02 0.25 ± 0.03
20:4n–6 1.23 ± 0.11 1.21 ± 0.02 0.19 ± 0.09 0.27 ± 0.14
20:5n–3 15.09 ± 0.09 15.35 ± 0.06 1.61 ± 0.17 1.81 ± 0.29
22:6n–3 10.74 ± 0.03 10.81 ± 0.11 2.31 ± 0.72 3.01 ± 1.00
TaBle 4 | growth performance and intestinal somatic index of european 
sea bass (Dicentrarchus labrax) fed the experimental diets at the end of 
the feeding trial (t = 60 days).
sgra isi (%)b
FO 1.10 ± 0.07 2.33 ± 0.19
FOMOS 1.19 ± 0.04 2.37 ± 0.08
SBO 1.08 ± 0.01 2.21 ± 0.13
SBOMOS 1.10 ± 0.02 2.19 ± 0.19
Two-way anova
Dietary oil (O) NS NS
MOS P < 0.05 NS
O × MOS NS NS
Values expressed in mean ± SD (n = 3 tanks/diet). Different letters within a column 
denote significant differences (P < 0.05) based on Tukey’s multiple range test (one-way 
ANOVA).
aSpecific growth rate (SGR) = [(ln final weight – ln initial weight)/number of days] × 100.
bIntestinal index (ISI) = (wet intestine weight/wet body weight) × 100.
NS, not significant.
TaBle 3 | Primers used for gene expression analysis by real-time Pcr in posterior gut of european sea bass (Dicentrarchus labrax) fed cMOs 
(t = 60 days).
gene name accession number Forward (5′ → 3′) reverse (5′ → 3′)
IL-1β Interleukin 1β AJ269472 ATTACCCACCACCCACTGAC TCTCTTCCACTATGCTCTCCAG-
IL-10 Interleukin 10 AM268529 ACCCCGTTCGCTTGCCA CATCTGGTGACATCACTC
TNFα Tumor necrosis factor α DQ200910 ACAGCGGATATGGACGGTG GCCAAGCAAACAGCAGGAC
IL-8 Interleukin 8 AM490063 GTCTGAGAAGCCTGGGAGTG GCAATGGGAGTTAGCAGGAA
IL-6 Interleukin 6 AM490062 ACTTCCAAAACATGCCCTGA CCGCTGGTCAGTCTAAGGAG
CD4 T-cell surface glycoprotein CD4 AM849811 GTGATAACGCTGAAGATCGAGCC GAGGTGTGTCATCTTCCGTTG
CD8α T-cell surface glycoprotein CD8 α chain AJ846849 CTAAGATTCGGCAAAATAACTCGAC GATGAGGAGTAGAAGAAGAAGGCC
MHCI Major histocompatibility complex class I AM943118 CAATACCTCACCCAGA CTCCATCTTTCCTCCAGAT
MHCII Major histocompatibility complex class II AM113466 CAGAGACGGACAGGAAG CAAGATCAGACCCAGGA 
TCRβ T-cell antigen receptor β chain AJ493441 GACGGACGAAGCTGCCCA TGGCAGCCTGTGTGATCTTCA
TGFβ Transforming growth factor β AM421619 GACCTGGGATGGAAGTGG CAGCTGCTCCACCTTGTG
COX2 Ciclo-oxigenase 2 AJ630649 CATTCTTTGCCCAGCACTTCACC AGCTTGCCATCCTTGAAGAGTC
IgL#18 (Ig) Immunoglobulin AJ400233 GAGCTGCAGGAGGACAGTG TCAGACTGGCCTCACAGCT
Casp-3 Caspase 3 DQ345773 CTGATTTGGATCCAGGCATT CGGTCGTAGTGTTCCTCCAT
Casp-9 Caspase 9 DQ345775 GGCAGGACTCGACGAGATAG CTCGCTCTGAGGAGCAAACT
β-actin β-actin AJ537421 ATGTGGATCAGCAAGCAGG AGAAATGTGTGGTGTGGTCG
August 2015 | Volume 6 | Article 3974
Torrecillas et al. Mannan-oligosaccharides soybean oil gut health
Frontiers in Immunology | www.frontiersin.org
source or MOS supplementation were established as fixed factors. 
Significant differences were considered when P <  0.05. Linear 
models (lme) were used to correlate individual genes with meas-
ures of mucous cell area, density, and their ratio. Further redun-
dancy analysis (RDA) was performed to correlate the immune 
gene expression with the histological structures configuration. 
Analyses were performed using the SPSS Statistical Software 
System v20.0 (SPSS, Chicago, IL, USA) and R (version 3.1.0).
results
growth Performance and  
intestinal somatic index
Whereas dietary inclusion of MOS significantly increased fish SGR 
as denoted by the two-way ANOVA [F(1,8) = 5.651, P < 0.05], 
complete replacement of FO by SBO only showed a tendency 
to reduce fish SGR (Table 4). Final fish weight (g ± SD) ranged 
between 38.06 ± 0.15 for fish fed SBOMOS and 39.97 ± 1.32 for 
fish fed FOMOS (58). No interaction was found between dietary 
oil (O) and MOS supplementation for SGR or an effect of MOS 
or SBO inclusion on ISI (Table 4).
Posterior gut lipid content and  
Fatty acid Profiles
Dietary MOS, oil source, or their interaction did not affect the 
posterior intestine lipid content. Lipid percentages ranged from 
27.99 ±  1.55 in fish fed SBOMOS to 30.48 ±  1.54 in fish fed 
FOMOS (g ⋅ 100 g−1 dry weight). Substitution of dietary FO by 
SBO resulted in lower (P < 0.05) saturated, n–3, n–3LC-PUFA, 
and n–3/n–6 fatty acids and higher (P <  0.05) n–6 and n–9 
fatty acids contents in posterior intestine (P < 0.05), regardless 
of dietary MOS inclusion. Indeed, the two-factor analysis of 
variance mainly attributed the variation in the main classes of 
fatty acids in tissue (P < 0.05) to dietary oil source irrespective 
of MOS dietary supplementation (Table 5). Thus, fish fed SBO 
diets presented a 8% lower posterior gut saturated fatty acids 
content when compared to fish fed FO-based diets, despite 
the 52% lower dietary content. This reduced the dietary/tissue 
content ratio from 0.95 in fish fed FO-based diets to 0.5 in fish 
fed SBO diets. Similarly, despite the 70% and 83% lower content 
of n–3 and n–3LC-PUFA in SBO-based diets, tissue percentages 
were reduced only by 37% and 43%, respectively. The DHA 
posterior intestine content was only reduced in fish fed SBO 
diet in relation to the rest of the treatments and, despite the 80% 
lower dietary ARA content for fish fed SBO-based diets, fish 
fed FOMOS, SBO, and SBOMOS diets presented almost similar 
posterior gut percentages, denoting a selective retention in this 
intestinal region. Indeed, the dietary/tissue ARA percentage ratio 
oscillated from 0.72 in fish fed FO-based diets to 0.18 for fish fed 
SBO-based diets (Table 5). Only the saturated fatty acids were 
significantly reduced by dietary MOS inclusion (F(1,8) =  6.31; 
P < 0.05) (Table 5). There was no interaction between oil source 
and prebiotic supplementation (Table 5).
Morphological studies
Posterior Intestine Morphometry
Morphological evaluation of the posterior gut sections revealed an 
intact epithelial barrier, organized villi, lack of debris in the lumen 
TaBle 5 | Posterior intestine main classes fatty acids profile (% of total identified fatty acids) of european sea bass (Dicentrarchus labrax) fed the 
experimental diets at the end of the feeding trial (t = 60 days).
Posterior intestine
FO FOMOs sBO sBOMOs MOs Oil M × O
Saturated 12.31 ± 0.36 12.21 ± 0.09 11.56 ± 0.16 11.08 ± 0.04 P < 0.05 P < 0.05 NS
Monoens 28.97 ± 2.53 29.99 ± 1.10 27.14 ± 0.36 27.77 ± 0.27 NS P < 0.05 NS
n–3 27.73 ± 2.97 27.74 ± 3.09 16.67 ± 1.92 17.86 ± 0.18 NS P < 0.05 NS
n–6 10.92 ± 0.32 10.65 ± 0.83 27.70 ± 1.47 27.19 ± 0.82 NS P < 0.05 NS
n–9 17.35 ± 1.33 18.02 ± 1.03 20.47 ± 0.28 20.86 ± 0.11 NS P < 0.05 NS
n–3 LC-PUFA 24.81 ± 3.17 24.94 ± 3.12 13.54 ± 2.04 14.54 ± 0.15 NS P < 0.05 NS
n–3/n–6 2.54 ± 0.23 2.63 ± 0.50 0.60 ± 0.09 0.66 ± 0.03 NS P < 0.05 NS
20:4n–6 1.74 ± 0.37 1.65 ± 0.10 1.33 ± 0.12 1.24 ± 0.03 NS P < 0.05 NS
20:5n–3 9.45 ± 0.59 9.67 ± 1.04 3.60 ± 0.82 3.89 ± 0.34 NS P < 0.05 NS
22:6n–3 13.26 ± 2.54 13.05 ± 1.85 8.89 ± 1.09 9.42 ± 0.22 NS P < 0.05 NS
Different letters within a line denote significant differences (P < 0.05) among dietary treatments (one-way ANOVA). Values expressed in mean ± SD (n = 3 tanks/diet).
NS, not significant.
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and no signs of edema or vasodilatation for all dietary treatments 
(Figure 1). Two-way ANOVA analyses revealed the effect on fold 
length of dietary oil source [F(1,8) = 96.25, P < 0.05] and MOS 
[F(1,8) = 52.57, P < 0.05], as well as the interaction between both 
factors [F(1,8) =  23.31, P <  0.05] (Table  6; Figure  1). Indeed, 
fish fed FOMOS diet had the longest intestinal folds and fish 
fed SBO diet had the shortest when compared with the rest of 
the groups. There was no effect (P>0.05, n = 250/tank) of MOS 
or dietary oil source or their combination on the mucosal folds 
width, although a trend to wider folds was observed in fish fed 
FOMOS diet (Table 6).
Mucosal Mapping™
In general, grand mean mucous cell areas patterns differed 
(P <  0.05) among tissues, with the largest mucous cells in the 
skin (170  μm2), followed by posterior gut (90  μm2), and the 
smallest in the anterior gut with an average of 82 μm2 (Figure 2). 
Additionally, there were significant differences in mean mucous 
cell areas within the posterior gut where both SBO and dietary 
MOS induced smaller cell areas (P < 0.05). Nevertheless, the two 
dietary components interact in a manner such that the addition 
of MOS to a SBO-based diet increases the mucous cell size over 
the values shown in fish fed FO-based diet. Finally in the skin and 
anterior gut, no differences were found due to dietary oil source 
or MOS supplementation.
The overall density of mucous cells in the epithelia was 
also affected by tissue. The posterior gut had a significantly 
higher density of mucous cells (P < 0.05), with about 10% of 
the mucosal epithelium composed of mucous cells compared 
to about 3.6% in the dorsolateral skin and 3.8% in the ante-
rior gut. Within these tissues, the anterior gut shows a trend 
(P = 0.05) to lower mucous cell density in fish fed SBO than in 
fish fed FO, regardless of dietary MOS inclusion (Figure 3A).
The ratio of epithelium to mucous cells (E:M) also shows 
tissue differences. The mean E:M ratio in both sections of the 
intestine was relatively low (between about 1500 and 3000 μm2 of 
epithelium per mucous cell) which is lower (P < 0.05) than that of 
the dorsolateral skin (Figure 3B). The SE of the mucous cell area 
measurements remains below the 10%, while all the other indexes 
remain below 30% (data not shown).
Posterior gut gene expression studies
No significant differences were observed in the expression of 
caspase-encoding genes among fish fed the different dietary 
treatments (data not shown). However, after 60 days of feeding, 
dietary treatments significantly affected the relative expression of 
MHCII, MHCI, CD4, CD8α, TCRβ, COX2, IL-1β, TNFα, IL-8, 
IL-6, TGFβ, IL-10, and Ig genes in the posterior gut of European 
sea bass (Table 7). In general, the two-way ANOVA test (Table 7) 
showed that dietary inclusion of SBO down-regulated (P < 0.05) 
the expression of TCRβ, COX2, IL-1β, TNFα, IL-8, IL-6, IL-10, 
TGFβ, and Ig genes and up-regulated (P <  0.05) MHCII gene 
expression (Table 7). Furthermore, results obtained indicate that 
MOS dietary inclusion affected (P < 0.05) MHCI, CD4, CD8α, 
COX2, TNFα, IL-8, IL-6, TGFβ, and Ig transcript levels regardless 
of dietary SBO supplementation (Table 7). An effect (P < 0.05) of 
the combination of both factors (MOS × oil source) was detected 
on MHCI, CD4, COX2, IL-1β, IL-6, TGFβ, and Ig relative gene 
expression. Particularly, it seems that inclusion of MOS in the 
SBO-based diet trends to up-regulate IL-6, TGFβ, and IL-10 
gene expression and in a lesser extends, IL-1β gene expression, 
counteracting the gene down-regulation effect of dietary SBO 
in comparison to dietary FO. Besides, the up-regulating effect 
of MOS inclusion in the FO-based diet on gene expression of 
MHCI, CD4, CD8α, COX2, TNFα, and Ig seems to be reduced 
when included in SBO-based diet (Table 7).
The principal component analysis (PCA) attributed 62.9% of 
the total variability on the posterior GALT-immune response 
in terms of relative gene expression to the dietary treatment 
(Figure  4). The first principal component (PC1) showed the 
influence of the dietary treatment on posterior gut gene expres-
sion and accounted for 41.84% of the total variability, PC1 axis 
separating FO-based diets from SBO diets. PC2 showed the influ-
ence of SBO or MOS addition to a FO diet without prebiotic on 
posterior gut relative gene expression and accounted for 21.08% 
of the total variability (Figure  4). Similarly the RDA indicated 
that the dietary treatment explains 47.64% of the total variability 
observed on posterior gut gene expression (P < 0.005). The first 
component (RDA1) explains 79.1% of the variability and cluster 
of all the genes, with exception of MHCII, on FO-based diets 
hemisphere. The rest of the variability (20.9%) is explained by the 
TaBle 6 | Folding intestine patterns for european sea bass (Dicentrarchus labrax) posterior intestine after 8 weeks of feeding trial.
Dietary treatment
FO FOMOs sBO sBOMOs MOs Oil M × O
Length (μm) 183.72 ± 3.50 186.90 ± 1.06 164.52 ± 1.32 180.36 ± 2.35 P < 0.05 P < 0.05 P < 0.05
Width (μm) 45.98 ± 1.44 50.82 ± 1.20 46.59 ± 4.99 46.95 ± 4.03 NS NS NS
Different letters within a line denote significant differences (P < 0.05) among dietary treatments. Values expressed in mean ± SD (n = 3 tanks/diet; n = 5 fish/tank).
NS, not significant.
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second component (RDA2) and clusters almost all genes related 
to cellular components on the axis upper space, where SBO and/
or MOS where supplemented and the humoral genes on the 
lower axis space in relation to the absence of dietary SBO or MOS 
(Figure 5). This indicates that (I) SBO dietary inclusion seems 
to exert a stronger effect than dietary MOS when supplemented 
in combination, (II) fish fed FO-based diets react better to MOS 
supplementation than fish fed SBO-based diets, (III) fish gene 
expression up-regulation after dietary MOS for 60  days seems 
to be centralized in cellular components, and (IV) SBO supple-
mentation caused an up-regulation of MHCII gene expression 
regardless of dietary MOS inclusion.
Discussion
growth Performance
Growth of European sea bass was not significantly affected by the 
complete replacement of FO by SBO in the present study, however, 
the FO provided by the dietary fish meal was in agreement with 
previous studies in the same species where up to 80% replace-
ment of FO by SBO fed for 63 days did not significantly affected 
FigUre 1 | Posterior gut (alcian Blue-Pas) from fish fed (a) Fish oil-based diet (FO), (B) FO- and MOs-based diet (FOMOs), (c) soy bean meal-based 
diet (sBO), and (D) sBO- and MOs-based diet (sBOMOs) after 60 days of supplementation.
growth of this species (59, 60). However, feeding 80% SBO diet for 
280 days significantly reduced SGRs (26, 60), in relation to the low 
contents on dietary LC-PUFA, which are known to be essential for 
growth (61). Similarly, in the present study there was a tendency in 
the SBO fed fish to have lower SGR, with fish fed SBO diet showing 
the lowest SGR. On the contrary, and in agreement with previ-
ous studies in the same fish species (44), MOS supplementation 
favored European sea bass SGR. Authors in ref. (44) related the 
dietary MOS positive effects on fish growth performance to (a) 
variations on absorption/incorporation rates of specific nutrients 
due to changes on intestinal pH; (b) a better functionality of the 
enterocyte membrane in terms of integrity and transcellular and 
paracellular transport rates due to changes in mucus proportions 
and composition; or (c) changes on the levels of peptides that 
control either the peripheral satiation system and the long-term 
system (51, 62) and provide information for the hypothalamic cen-
tral feeding system that controls feed intake. Moreover, the SGR 
of fish fed SBO with MOS supplementation tended to be similar 
to that of European sea bass fed FO, thus potentially neutralizing 
the negative effect of SBO. However, the long-term effects of the 
complete FO replacement by SBO in diets supplemented with 
FigUre 2 | Top left: histological sections of anterior gut (left) and 
posterior gut (center) fed with (a) FO- and (B) sBO-based diets, 
stained in alcian Blue-Pas. Top right: histological section of skin fed with 
fish oil and stained with Toluidine Blue (scale bar = 300 μm). Bottom: 
Mucous cell area (μm2) depending on tissue and diet. From left to right: 
anterior gut, posterior gut, and skin, differentiated significantly by a dotted 
line (P = 2e–16, F-test). Green color is soybean oil and blue color is fish oil. 
N = 36 fishes.
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MOS should be further studied to determine the optimal MOS 
dose and time of supplementation in relation to fish age (44).
Posterior gut lipid composition and Fatty acid 
Profiles
Neither dietary oil source nor prebiotic supplementation affected 
intestine lipid content, in agreement with previous studies (32, 
63). Indeed, posterior intestine fatty acid profiles mainly reflected 
diet composition. However, it is remarkable that higher tissue 
saturated, n–3 and n–3LC-PUFA fractions in relation to their 
particular dietary content for fish fed SBO-based diets compared 
to fish fed FO-based diets, was in agreement with previous studies 
(32, 60), denoting the importance of these groups of fatty acids 
for the correct functioning of intestinal cells. Particularly, the 
FigUre 3 | (a) Cell density (%) depending on the tissue and diet. From left 
to right: anterior gut, posterior gut, and skin, differentiated significantly by a 
dotted line (P = 4.23e–14, F-test). Green color is SBO and blue FO. N = 36 
fishes. (B) Total epithelium per mucous cell (μm2) depending on the tissue 
and the diet. Organs are significantly separated by a dotted line (P = 1.2e–
11, F-test) being anterior and posterior gut in the left side, and skin in the 
right side of the line. Green color is soybean oil and blue fish oil. N = 36 
fishes.
August 2015 | Volume 6 | Article 3978
Torrecillas et al. Mannan-oligosaccharides soybean oil gut health
Frontiers in Immunology | www.frontiersin.org
increased deposition of total n–3 and n–3LC-PUFA, mainly as 
a consequence of a higher DHA and EPA tissue content, could 
be related to the preferential esterification of these fatty acids 
into intestinal polar lipids on the anterior gut independently 
of their dietary content as described before for this and other 
marine fish species (32, 60). In addition, preferential assimilation 
of LC-PUFAs in relation to a higher affinity of intestinal lipases 
and fatty acid-binding proteins (32, 64, 65) would also contribute 
to the high n–3LC-PUFA content in intestinal tissue. Besides, 
the almost comparable saturated percentages in posterior gut 
FigUre 5 | redundancy analysis (rDa) to study the variability 
posterior gut relative gene expression as response dietary treatment. 
The points correspond to the tanks and are colored according to their diet, 
being FO, fish oil; FOMOS, fish oil and MOS; SBO, soybean oil; SBOMOS, 
soybean oil and MOS.
FigUre 4 | Principal component analysis (Pca) to study the variability 
on the posterior gut relative gene expression in relation to dietary 
treatment. The points correspond to the tanks and are colored according to 
their diet, being FO, fish oil; FOMOS, fish oil and MOS; SBO, soybean oil; 
SBOMOS, soybean oil and MOS.
TaBle 7 | Posterior gut relative gene expression profile of european sea bass (Dicentrarchus labrax) juveniles determined by rT-Pcr after 60 days of 
dietary supplementation.
Dietary treatment Two-way anOVa
FO FOMOs sBO sBOMOs MOs Oil M × O
MHCII 1.01 ± 0.12 1.14 ± 0.04 2.16 ± 0.43 1.88 ± 0.32 NS P < 0.05 NS
MHCI 1.03 ± 0.26 3.13 ± 0.15 0.77 ± 0.12 1.00 ± 0.26 P < 0.05 P < 0.05 P < 0.05
CD4 1.10 ± 0.17 2.02 ± 0.28 0.77 ± 0.09 1.07 ± 0.14 P < 0.05 NS P < 0.05
CD8α 1.04 ± 0.25 1.62 ± 0.46 1.11 ± 0.33 1.49 ± 0.32 P < 0.05 P < 0.05 NS
TCRβ 1.04 ± 0.14 1.44 ± 0.14 0.82 ± 0.30 0.81 ± 0.30 NS P < 0.05 NS
COX2 1.09 ± 0.16 1.76 ± 0.13 0.50 ± 0.09 0.66 ± 0.09 P < 0.05 P < 0.05 P < 0.05
IL-1β 1.06 ± 0.16 1.02 ± 0.08 0.53 ± 0.13 0.83 ± 0.10 NS P < 0.05 P < 0.05
TNFα 1.04 ± 0.12 1.98 ± 0.26 0.87 ± 0.13 1.27 ± 0.43 P < 0.05 P < 0.05 NS
IL-8 1.08 ± 0.38 0.75 ± 0.11 0.71 ± 0.21 0.35 ± 0.20 P < 0.05 P < 0.05 NS
IL-6 1.05 ± 0.22 0.57 ± 0.01 0.39 ± 0.05 0.48 ± 0.04 P < 0.05 P < 0.05 P < 0.05
TGFβ 1.06 ± 0.17 0.26 ± 0.02 0.32 ± 0.02 0.60 ± 0.05 P < 0.05 P < 0.05 P < 0.05
IL-10 1.02 ± 0.13 1.06a ± 0.06 0.60 ± 0.09 0.75 ± 0.05 NS P < 0.05 NS
IgL#18 1.06 ± 0.23 1.75 ± 0.03 0.48 ± 0.14 0.58 ± 0.23 P < 0.05 P < 0.05 P < 0.05
Different letters within a line denote significant differences (P < 0.05) among dietary treatments (one-way ANOVA; Tukey’s test). Values expressed in mean ± SD of two pools of three 
specimens analyzed per tank (n = 3 tanks/diet).
NS, not significant.
August 2015 | Volume 6 | Article 3979
Torrecillas et al. Mannan-oligosaccharides soybean oil gut health
Frontiers in Immunology | www.frontiersin.org
of fish fed SBO- and FO-based diets, despite a different dietary 
intake, denote a high production of these fatty acids in the liver 
in relation to their importance as constituents of membrane polar 
lipids, particularly of the phosphatidylcholine fraction (32, 66, 
67). In this sense, previous studies have demonstrated that MOS 
supplementation increases the polar lipid fraction in European 
sea bass posterior gut, predominantly of the first resultant com-
pounds of phospholipids synthesis (phosphatidylcholine and 
phosphatidylethanolamine), but also phosphatidylserine and 
phosphatidylinositol, in relation to a better intestinal mucosal 
integrity and to a higher production of prostaglandins levels after 
stimulation (63). Indeed, the slightly lower content of posterior 
gut ARA in fish fed MOS, regardless of dietary levels, could be 
related to an enhanced prostaglandins production as conse-
quence of a higher number of infiltrated leukocytes in this tissue 
as previously demonstrated for the same fish species (63).
gut Morphology and Mucous cell Dynamics
Regional differences in form and function of the gut are found 
in response to basic diet but differential effects are found due to 
MOS supplementation. In the anterior gut, where most entero-
cytes are absorptive (68), mucous cell densities are significantly 
higher in European sea bass given the FO diet than the SBO diet, 
thus supporting a possible higher mucous secretion. The density 
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of mucous cells in the posterior gut epithelia was significantly 
higher relative to the anterior gut in all treatments, supporting 
many studies showing more mucus cells in the hindgut relative 
to the foregut (69). However, within the posterior intestine, 
the mucosal epithelium reacts to the dietary presence of SBO 
and MOS by decreasing the mucous cell size when MOS was 
combined with FO and increasing it when combined with SBO, 
however, this results in similar E:M ratios and thus modulates 
the mucosal dynamics. A similar regional disparity has been 
found in rainbow trout (Oncorhynchus mykiss) immune response 
to a challenge with Aeromonas salmonicida, where the foregut 
up-regulated IL-1β, TNF-α, interferon INFγ, IL-8, and TGFβ 
gene expression, whereas the hindgut only down-regulated its 
baseline expression of TGFβ (70). This differential picture of the 
action of mucous cells and epithelial cells suggests that far more 
is being activated in both gut segments and that mucosal mapping 
synthesizes the effects of many more genes than those which are 
typically targeted.
In the skin, mucous cell areas, densities and E:M were not 
significantly different between treatments although there was a 
tendency to smaller cells at a higher E:M ratio in the FO group 
(not significant). The mean mucous cell areas of dorsolateral skin 
in European sea bass ranged from about 150 to 200 μm2, similar 
to Atlantic salmon (Salmo salar) with a mean of about 160 μm2 
(52). However, densities in the dorsolateral of European sea bass 
are generally below 5% of the epithelium, which is lower than the 
7–10% found in the Atlantic salmon dorsolateral but about equal 
to the low density found on the salmon head and dorsal caudal 
peduncle (52). This method also allows distinction of regions 
with differing mucous cell characteristics, as found across the sal-
monid body (52, 71, 72) or in response to antiparasitic treatments 
(73). Patterns of mucous cell distribution may be correlated with 
differential gene expression and be a vital clue to innate immune 
responses to a variety of pathogens and inflammatory agents.
The index E:M showed significantly more epithelium per 
mucous cell (E:M) and significantly larger mucous cell areas in 
the skin than in both gut segments that were not affected by diet. 
However, the density of skin mucous cells was equal to the anterior 
gut and significantly lower than that of the posterior guts, and not 
affected by MOS or oil source. This is in accordance with previ-
ous studies in the same species fed FOMOS diets where intestinal 
mucus presented enhanced immune activity in terms of lysozyme 
and bactericidal activities when compared to fish fed FO diets, 
but this effect was not detected in skin mucus (44). This suggests 
that, in the unchallenged skin, the diet composition posed no 
inherent immune challenge to skin mucosa and did not stimulate 
differential innate immune responses, in contrast to parasitic 
challenges, which do induce changes in skin mucous cell dynam-
ics in salmon (Pittman and Campo, personal communication). 
However, despite similar structures between mammalian and 
teleost mucosal epithelia in the gut and skin, teleost skin has liv-
ing cells on the surface as opposed to the keratinized mammalian 
skin (74). As such the pathogen-associated molecular patterns 
(PAMPs) can be interpreted and transmitted rapidly by the living 
teleostean epithelial cells, giving changed skin mucus properties 
change in response to bacterial load in the water, as is found in 
carp (74, 75). However, some salmonids (Salmo salar and Salmo 
trutta) exhibit a whole-body mucus immune response (skin, gills) 
to Amoebic Gill Disease, while rainbow trout (Oncorhynchus 
mykiss) has only a local response in the gills (76). Therefore, we 
cannot exclude the possibility of a latent differential skin response 
to immune challenges in European sea bass fed different diets.
immune genes expression
Fish gut epithelium acts and reacts as the first line of protection 
against any potentially harmful substances/pathogens, dealing 
continuously with the resident microbiota, fish external environ-
ment, and substances/molecules coming from feeding. The results 
of the present study denoted a clear difference in the expression 
of GALT-related genes in the posterior gut of European sea bass 
fed for 60 days with diets containing either FO or SBO, denoting 
the importance of the dietary fatty acid profile on the immune 
system of marine fish, in agreement with previous studies (6, 77). 
Whereas MOS dietary supplementation in the FO-based diet 
exerted a clear up-regulation of genes related to GALT-cellular 
components, MOS addition to SBO-based diets had a milder 
effect. These results suggest that under a SBO-based diet, the fish 
GALT system is rendered less capable of mounting a response to 
MOS due to a lower substrate availability, an effect that is more 
consistent with the presence of SBO than with the presence of 
MOS. Nevertheless, the different pattern of GALT-related genes 
expression found for MOS and SBO containing diets in compari-
son to FO-based diets would be related to a response to non-self 
substances or to potential changes in the microflora caused 
by dietary supplementation with SBO (39) or MOS (78–80). 
However, both GALT-immune-related genes responses differed 
between SBO and MOS.
Mannan oligosaccharides supplementation, particularly in 
FO-based diets, triggered a posterior gut response by increasing 
posterior gut TNFα, CD4 and CD8 gene expression, denoting 
a T-cell-mediated inflammation. Interestingly, a concentrated 
product of MOS (cMOS; second-generation product) did not 
affect the expression of these genes (81), this is probably related 
to the lack of some residual components of the outer cell wall 
of Saccharomyces cerevisiae lost during the production process, 
such as β-glucans. TNFα is a proinflammatory cytokine released 
by macrophages or activated T-cells in response to PAMPs that 
play a key role as a chemotactic agent leading to the migration of 
leukocytes to the inflammation site (82, 83). Leukocyte migration 
is promoted in the posterior gut of European sea bass after MOS 
supplementation as described in previous studies by electron 
and optical microscopy [for review see Ref. (44)]. Studies on 
leukocytes in higher vertebrates attributed the stimulatory effect 
of yeast cell wall components on TNFα production/expression to 
NF-Kβ activation (83, 84) probably triggered by dectin-1 expres-
sion (85–88). However, in the present study, activation through 
mannose receptor (MR) or DC-SING and/or a modulation of 
the TLR3 and TLR4 should not be discarded (88–91). Besides, 
exposing the fish to an external agent like MOS over a relatively 
long (2 months) period in terms of immediate GALT response 
may have affected the pleiotropic role of TNFα (proinflamma-
tory and immunosuppressive effects) and could influence the 
regulation of IL-6 production by antigen-presenting cells (APCs) 
(92). This could have contributed to attaining a possible state of 
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homeostasis by the end of the experiment. Indeed, a higher level 
of TNFα transcripts in the absence of IL-10 response is normally 
associated with increased mucosal IL-17 in humans (93, 94) 
which together with IL-22 induces the production of bactericidal 
and bacteriostatic peptides by enterocytes (94, 95) and promotes 
gut integrity via increasing barrier forming claudin proteins and 
wound healing (95–98) as previously described for fish fed MOS 
during a similar period of time (44).
Mannan oligosaccharides supplementation also up-regulated 
CD4 and CD8 gene expression, suggesting the promotion of 
T-cell-specific responses by yeast cell wall components via these 
and other cytokines, as INFγ (84). These elevated transcripts 
levels could be the consequence of variations in the microbiota 
populations as previously described for fish fed MOS (78–80), 
since T-cells are extremely important in creating tolerance or 
immunity against commensal microbiota. In the present study, 
dietary MOS in FO-based diets could also promote cytotoxic 
T-cell immune response by up-regulating MHCI gene expression, 
much like in porcine bronchoalveolar lavage fluid cells (99), high-
lighting the role not only of APCs but also of any nucleated cell on 
MOS-derived GALT-related immune genes response. Contrary 
to this, SBO strongly up-regulated the expression of MHCII gene 
relative to FO, indicating possible alterations on leukocytes popu-
lations other than T-cells, such as macrophages or granulocytes, 
as previously reported for the same fish species (100). This could 
be induced by changes in the microbiota composition and/or 
on the short-chain fatty acids (SCFAs), such as butyrate, acetate, 
formate, or propionate, which can either induce mucin synthesis 
and mucous production or inhibit mucin synthesis in vitro, sup-
porting their role in regulating mucous cell differentiation (101). 
These SCFAs are also end-metabolites produced by the microbiota 
and profoundly influence gut barrier function, as well as host 
immunity and cell proliferation (102). Indeed, previous studies 
in salmon gut epithelium fed SBM demonstrated that MHCII 
molecules have a polyclonal role on the gut epithelium endocytic 
and/or exocytic uptake, processing and presentation of luminal 
agents associated with maintaining intestinal homeostasis (103).
Soybean oil inclusion down-regulated COX2 expression in 
posterior gut of European sea bass, in relation to the alterations 
on the substrate EPA and ARA membrane contents in this tissue 
as well as on the EPA/ARA ratio. Inhibition of COX2 activ-
ity by dietary lipids has been related to a lower production of 
prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) in fish fed 
SBO-based diets (10, 104–107). On the contrary, MOS inclusion 
increased COX2 transcripts. Indeed, the slightly lower content 
of tissue ARA in European sea bass fed MOS could be related 
to an enhanced PGs production as a consequence of a higher 
number of infiltrated leukocytes as previously described for the 
same species fed FO-based diets with MOS supplementation (62). 
Furthermore, PGs affect transcription of several genes involved 
in T-cell activation, physicochemical properties, and discharging 
rates of intestinal mucus and produce the closure of tight junctions 
via restoring occludin and ZO-1 through phosphatidylinositol-
3-kinase pathway (62) as a mechanism of repairing epithelial 
barrier after external aggression in agreement with an improved 
conserved cytoarchitecture of the enterocyte in fish fed FOMOS 
[for review see Ref. (44)].
Activated T-cells levels may also trigger B cell activation and Ig 
production. Thus, in agreement with the COX2 down-regulation 
and potentially impaired T-cell activation, IgM chain gene expres-
sion was also down-regulated by dietary SBO inclusion. Contrary 
to this, the increased expression of IgM chain in posterior gut of 
fish fed FO-based diets with MOS points to a higher production 
of Ig in this intestinal section (81), and a higher plasmatic cell 
density compared to that of fish fed an FO diet (80). However, the 
effect of SBO over the B cell population in terms of IgM relative 
gene expression seems to be stronger than the one caused by MOS 
itself and points again to fish system incapability of responding 
properly to the MOS stimulus in fish fed SBO.
Regarding GALT humoral components, feeding SBO leads to 
a down-regulation of IL-1β expression, in the posterior intestine 
of European sea bass. On the contrary, expression of these genes 
in whole intestine of Solea senegalensis was not affected by dietary 
inclusion of SBO (77), what could be related to the different spe-
cies, experimental conditions, or intestinal section evaluated. 
Indeed, among the different sections of the intestinal tract GALT 
activity and microbiota profiles have been found to differ (44) as 
well as the morphological alterations caused by SBO (29, 32, 34). 
MOS supplementation to SBO diets only mildly up-regulated the 
IL-1β gene expression in posterior gut equaling that found in FO 
fed fish, and, in agreement with previous studies (81), did not 
affect the expression of this gene when it was supplemented to FO 
diets. Studies in higher vertebrates peripheral mononuclear blood 
cells indicate that dietary MOS inclusion, rather than IL-1β, 
affects IL-1α (99), which stimulates growth and differentiation 
factors that trigger cellular proliferation and migration events in 
response to immunological insults (99).
Fish oil substitution by SBO also down-regulated IL-10 rela-
tive expression, in agreement with the morphometric decrease 
of the mucous barrier in this fish by decreasing the fold length. 
It is demonstrated that IL-10 preserves the mucous barrier and 
maintains mucin production by not exerting a stress effect on the 
endoplasmic reticulum of the mucous cells (108). MOS inclusion 
in SBO diets markedly up-regulated IL-10, denoting its important 
role for mucous barrier strength, increasing the mucous cell area 
and restoring the normal fold length in this fish. Similarly, dietary 
SBO down-regulated gene expression of TGFβ, whereas MOS 
inclusion in SBO diets up-regulated the expression of this gene. 
TGFβ plays a crucial role in maintaining immune homeostasis 
and preventing mucosal inflammation via regulating lymphocytes 
and phagocytes activation (109, 110). Therefore, MOS induced a 
homeostatic balance in the posterior gut mucosal tissue of fish fed 
SBO almost to the same level as with FO diets.
general Overview
After the use of FO and FM alone in the feed for European sea bass, 
there are signals for high cell proliferation and proinflammatory 
agents and cell transforming factors, which also include apoptosis. 
This indicates that the FO diet induced, in European sea bass 
intestine, a good epithelial turnover combined with differentiation 
of cells and that the high TGFβ perhaps directs any functional 
trans-differentiation of the epithelial to the mucous cells. On the 
other hand, in the SBO group, the entire architecture of the gut 
was affected, beyond the region of the lumen, inducing shorter 
August 2015 | Volume 6 | Article 39712
Torrecillas et al. Mannan-oligosaccharides soybean oil gut health
Frontiers in Immunology | www.frontiersin.org
intestinal folds and lower mucous cell density in the anterior gut 
than in the FO-based diets, but with average mucous cell sizes and 
relative amounts of epithelium to mucous cell. However, the poste-
rior gut has only average values for the mucous cell dynamics sug-
gesting a possible immune function of the anterior gut modulating 
the immune response of the next gut segment. Additionally, there 
is a down-regulation of immune genes like receptors on T-cells 
and those agents mediating inflammation. There is more MCHII 
to interact with cytokines but conversely there are decreases in 
most cytokines as well as in agents for cell proliferation, pro- and 
anti-inflammatories, cell death and differentiation, and fewer 
innate Igs. The overall view is that SBO influences processes such 
as fundamental cell cycling and determination and reduces the 
fish’s capacity to mount an immune response.
The addition of MOS to FO-based diet (FOMOS) resulted in 
more tightly packed mucous cells than in SBOMOS (less epithe-
lium to mucous cell). There was also more surface-to-volume 
because of the small size of mucous cells allowing more efficient 
diffusion of immune contents in the posterior gut. Indeed, the 
overall results of gene expression point to a T-cell-mediated 
inflammation in fish fed FOMOS. This diet induces the highest 
reactivity to inflammation and the most Igs, but has average cell 
migration and proliferation. The results indicate a strengthening 
of the reactivity of the innate immune system without increasing 
or changing cell number, and a slightly increased ability for such 
immune substances to diffuse from a mucous cell in the posterior 
gut. Indeed, the addition of MOS to the SBO diet tended to neu-
tralize the short folds induced by SBO alone, suggesting that one 
action of MOS is on substances impacting cell determination at 
levels below the IECs and probably in the lamina propria and the 
submucosa. The anterior mucous cells have an enhanced ability 
to diffuse immune molecules (smaller mucous cells). Relative to 
the FOMOS group, the SBOMOS diet in the anterior gut may 
induce some hyperplasia of the epithelium or a reduction in 
the transdifferentiating capacity of the epithelial cells to make 
mucous cells (the interpretation can go both ways). The posterior 
gut shows greater storage of mucous cell contents and possible 
dysregulation of the gut, but no hyperplasia of the epithelium or, 
alternately, no dysregulation of the trans-differentiation capac-
ity of epithelial cells to mucous cells. Relative to the SBO, this 
MOS-supplemented diet gives the lowest cell migration, con-
curring with the mucous cell configurations, but enhanced cell 
proliferation which possibly favors the hypothesis of epithelial 
hyperplasia, along with generally more cell differentiation and 
turnover, and more anti-inflammatories. However, the overall 
profile of the gastrointestinal tract given SBO-based diets has not 
attained the level maintained by a pure fish diet.
Thus, the addition of MOS neutralized the short folds induced 
by SBO, suggesting that MOS acts on the SBO substances at the 
level of mucous cell differentiation in the epithelial cells but also 
at levels below the IECs and probably in the lamina propria and 
the submucosa. Authors in reference (44) connected the dietary 
MOS positive effects on fish growth performance to a better 
functionality of the enterocyte membrane in terms of integrity 
and transcellular and paracellular transport rates due to changes 
in mucus proportions and composition. In this study, when MOS 
is combined with SBO the effect on SGR is weakened, support-
ing the hypothesis of functionality of the membrane, but further 
indicating that the primary action of MOS when given at this 
dose is to neutralize the dysregulation induced by SBO, rather 
than enhancing other immune functions. A dysregulation of the 
tight control exerted on innate immunity and tissue integrity in 
the intestine can also lead to tissue irritation and/or inflamma-
tion. The microbiota supported by our differing diets has not been 
analyzed but their action on the genetic and mucosal results sug-
gests that their composition may influence antigen signaling (45).
general conclusion
The results of this study have shown that complete replacement 
of FO by SBO, in addition to the FO provided by the dietary fish 
meal itself, markedly affects the morphology and physiology of 
the European sea bass gut, altering the fatty acid profile of gut, 
down-regulating genes related to both humoral and cellular 
GALT in the posterior gut, reducing mucous cell density in the 
anterior gut, and reducing fish growth. Inclusion of MOS in diets 
with complete replacement of FO by SBO partially compensated 
for the negative effects of the VO by increasing the mucous 
cell density and the mucous cell area in the posterior gut and 
partially compensating the down-regulation caused by SBO in 
the expression of certain genes such as IL-6, IL-10, and TGFβ, 
which are related to the functioning of the mucous barrier and 
maintain immune homeostasis. Thus, MOS was found to be a 
homeostatic balancer of the mucosal barrier in the posterior gut. 
However, MOS inclusion in SBO diets was not able to counteract 
the up-regulation of MHCII or down-regulation of COX2, sug-
gesting that with a SBO-based diet, the fish immune system is 
rendered incapable of mounting a complete GALT-immune 
response against MOS. Patterns of mucous cell distribution may 
be correlated with differential gene expression and be a vital clue 
to innate immune responses to a variety of pathogens and inflam-
matory agents. Nevertheless, the observed effects of both dietary 
oils and MOS on European sea bass gut must be the results of 
species-, gut region-, diet-, and immune stimulant-specific inter-
actions within the gut responses, as well as differential actions on 
microbial composition. Further research in the tight junctions 
between intestinal epithelial cells and MOS might illustrate the 
mechanisms of recovering fold length and therefore intestinal 
barrier.
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